301 related articles for article (PubMed ID: 37418332)
1. Expanded table: Some drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e115-e119. PubMed ID: 37418332
[No Abstract] [Full Text] [Related]
2. Drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2023 Jul; 65(1680):105-112. PubMed ID: 37418329
[No Abstract] [Full Text] [Related]
3. Comparison table: some drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2018 Jul; 60(1550):e117-e122. PubMed ID: 30036356
[No Abstract] [Full Text] [Related]
4. Drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2018 Jul; 60(1550):107-114. PubMed ID: 30036352
[No Abstract] [Full Text] [Related]
5. Ozanimod (Zeposia) for ulcerative colitis.
Med Lett Drugs Ther; 2021 Sep; 63(1633):147-151. PubMed ID: 34550962
[No Abstract] [Full Text] [Related]
6. Upadacitinib (Rinvoq): A second JAK inhibitor for ulcerative colitis.
Med Lett Drugs Ther; 2022 Sep; 64(1658):142-144. PubMed ID: 36094554
[No Abstract] [Full Text] [Related]
7. Mirikizumab (Omvoh) for ulcerative colitis.
Med Lett Drugs Ther; 2024 Mar; 66(1698):46-47. PubMed ID: 38466213
[No Abstract] [Full Text] [Related]
8. Risankizumab (Skyrizi) - An IL-23 antagonist for Crohn's disease.
Med Lett Drugs Ther; 2022 Dec; 64(1666):153-157. PubMed ID: 36542348
[No Abstract] [Full Text] [Related]
9. Table: Some drug interactions with drugs for IBD.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e114. PubMed ID: 37418331
[No Abstract] [Full Text] [Related]
10. Table: drugs for ulcerative colitis.
Med Lett Drugs Ther; 2018 Jul; 60(1550):e114. PubMed ID: 30036353
[No Abstract] [Full Text] [Related]
11. Etrasimod (Velsipity) for ulcerative colitis.
Med Lett Drugs Ther; 2023 Nov; 65(1690):187-189. PubMed ID: 37983118
[No Abstract] [Full Text] [Related]
12. Drugs for psoriatic arthritis.
Med Lett Drugs Ther; 2019 Dec; 61(1588):203-210. PubMed ID: 31999665
[No Abstract] [Full Text] [Related]
13. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 2021 Nov; 63(1637):177-184. PubMed ID: 35085210
[No Abstract] [Full Text] [Related]
14. Table: safety of drugs for IBD in pregnancy.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e113. PubMed ID: 37418330
[No Abstract] [Full Text] [Related]
15. Table: safety of drugs for IBD in pregnancy.
Med Lett Drugs Ther; 2018 Jul; 60(1550):e116. PubMed ID: 30036355
[No Abstract] [Full Text] [Related]
16. Drugs for rheumatoid arthritis.
Med Lett Drugs Ther; 2018 Jul; 60(1552):123-128. PubMed ID: 30044766
[No Abstract] [Full Text] [Related]
17. Expanded table: some drugs for psoriasis.
Med Lett Drugs Ther; 2019 Jun; 61(1574):e96-e103. PubMed ID: 31381545
[No Abstract] [Full Text] [Related]
18. Expanded Table: Some biologic drugs and JAK inhibitors for rheumatoid arthritis.
Med Lett Drugs Ther; 2021 Nov; 63(1637):e187-e189. PubMed ID: 35085212
[No Abstract] [Full Text] [Related]
19. Pharmacological Management of Inflammatory Bowel Disease: a Century of Expert Opinions in Cecil Textbook of Medicine.
Manu P; Rogozea LM; Dumitraşcu DL
Am J Ther; 2022 Sep-Oct 01; 29(5):e500-e506. PubMed ID: 36048564
[TBL] [Abstract][Full Text] [Related]
20. Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives.
Rawla P; Sunkara T; Raj JP
J Inflamm Res; 2018; 11():215-226. PubMed ID: 29844695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
